Dr. Robert Rissmann studied pharmacy at the Free University of Berlin, Germany. He obtained the license to practice as a pharmacist in 2004. Subsequently, he began a PhD project in drug delivery at the Leiden Academic Center for Drug Research (Leiden University), focusing on translational dermatology. Robert successfully defended his PhD thesis on skin pharmacology in 2009. From 2010 to 2017, he was the Director of Education at the Centre for Human Drug Research (CHDR), emphasizing clinical pharmacology and pharmacotherapeutics. His research interests concern translational models in both immunology and dermatology for drug development in early-phase clinical research. He was a member of the educational and executive board of the Dutch Society of Clinical Pharmacology and Biopharmacy (2012-2023). In 2015 he was appointed Associate Professor at the Leiden University Medical Center. He has published over 100 manuscripts in peer-reviewed journals and is actively involved in supervising and training PhD students. Since 2017, he has held the position of Research Director in Dermatology and heads the Skin Pharmacology research group at CHDR. In 2020, he was appointed Professor of Translational Dermatology at Leiden University.